Conceptus(R) Names David H. Chung As New Chief Commercial Officer
MOUNTAIN VIEW, Calif., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the Essure ® procedure, the leading surgery-free permanent birth control method, announced today that it has appointed medical device industry executive David H. Chung to the newly-created position of Chief Commercial Officer and Executive Vice President, effective immediately. Mr. Chung has more than 20 years of experience building world-class commercial organizations within the field of implantable medical devices. He will lead the Company's global sales and marketing strategies and report directly to Conceptus President and Chief Executive Officer, D. Keith Grossman.
Mr. Chung joins Conceptus from Mitralis Medical, where he served as the President and Chief Executive Officer of this early-stage transcatheter mitral valve repair company since 2011. Previously, he spent 15 years with Edwards Lifesciences/Baxter Healthcare where he held sales, marketing, and commercial operations leadership positions with increasing scale and responsibility. From 2008 to 2011, Mr. Chung served as Global Vice President, Commercial Operations, Heart Valve Therapy, and from 2003 to 2008 as Vice President, Sales and Marketing, Heart Valve Therapy. From 1996 to 2003, Mr. Chung held a variety of sales, sales operations and marketing positions for Edwards.
Prior to Edwards Lifesciences, Mr. Chung held sales positions at Pfizer-Schneider Interventional Cardiology from 1994 to 1996 and Pfizer-Pharmaceuticals Roerig Division from 1991 to 1994.Mr. Chung served as a PATRIOT Missile officer in the United States Army from 1988 to 1991 and received a B.S. degree in General Engineering and International Relations at the United States Military Academy at West Point. "Our new Chief Commercial Officer role demands an individual with a strong leadership profile and a proven track record in the medical device industry to take our commercial programs to the next level. David's exceptional experience in driving successful sales and marketing initiatives with world-class companies in high-growth medical device markets makes him ideally suited to lead Conceptus' worldwide commercial activities. We are very pleased that David has accepted this responsibility, which will be pivotal to the future growth of the Company," said Mr. Grossman.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts